63 related articles for article (PubMed ID: 23295255)
21. Prognostic significance of serum levels of vascular endothelial growth factor and insulin-like growth factor-1 in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Oh SY; Kwon HC; Kim SH; Lee S; Lee JH; Graves CA; Camphausen K; Kim HJ
Chemotherapy; 2012; 58(6):426-34. PubMed ID: 23295255
[TBL] [Abstract][Full Text] [Related]
22. The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer.
Oh SY; Kwon HC; Kim SH; Lee S; Lee JH; Hwang JA; Hong SH; Graves CA; Camphausen K; Kim HJ; Lee YS
BMC Cancer; 2013 Feb; 13():43. PubMed ID: 23374220
[TBL] [Abstract][Full Text] [Related]
23. Relationship between insulin-like growth factor axis gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX.
Oh SY; Shin A; Kim SG; Hwang JA; Hong SH; Lee YS; Kwon HC
Oncotarget; 2016 May; 7(21):31204-14. PubMed ID: 27144430
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
De Vita F; Orditura M; Matano E; Bianco R; Carlomagno C; Infusino S; Damiano V; Simeone E; Diadema MR; Lieto E; Castellano P; Pepe S; De Placido S; Galizia G; Di Martino N; Ciardiello F; Catalano G; Bianco AR
Br J Cancer; 2005 May; 92(9):1644-9. PubMed ID: 15856038
[TBL] [Abstract][Full Text] [Related]
26. Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status.
Petrioli R; Francini E; Roviello F; Marrelli D; Miano ST; Fiaschi AI; Laera L; Bellini MA; Roviello G
J Geriatr Oncol; 2015 Sep; 6(5):380-6. PubMed ID: 26228711
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.
Peng L; Zhan P; Zhou Y; Fang W; Zhao P; Zheng Y; Xu N
Mol Biol Rep; 2012 Oct; 39(10):9473-84. PubMed ID: 22729879
[TBL] [Abstract][Full Text] [Related]
28. The insulin and insulin-like growth factor receptor family in neoplasia: an update.
Pollak M
Nat Rev Cancer; 2012 Feb; 12(3):159-69. PubMed ID: 22337149
[TBL] [Abstract][Full Text] [Related]
29. A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer.
Xiang XJ; Zhang L; Qiu F; Yu F; Zhan ZY; Feng M; Yan J; Zhao JG; Xiong JP
Chemotherapy; 2012; 58(1):1-7. PubMed ID: 22310723
[TBL] [Abstract][Full Text] [Related]
30. The role of chemotherapy in metastatic gastric cancer.
Pasini F; Fraccon AP; DE Manzoni G
Anticancer Res; 2011 Oct; 31(10):3543-54. PubMed ID: 21965776
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis.
Chen J; Li T; Wu Y; He L; Zhang L; Shi T; Yi Z; Liu M; Pang X
J Cancer Res Clin Oncol; 2011 Dec; 137(12):1799-812. PubMed ID: 21918901
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphism of IGF-I predicts recurrence in patients with gastric cancer who have undergone curative gastrectomy.
Shitara K; Ito S; Misawa K; Ito Y; Ito H; Hosono S; Watanabe M; Tajima K; Tanaka H; Muro K; Matsuo K
Ann Oncol; 2012 Mar; 23(3):659-664. PubMed ID: 21690232
[TBL] [Abstract][Full Text] [Related]
33. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008.
Jung KW; Park S; Kong HJ; Won YJ; Lee JY; Park EC; Lee JS
Cancer Res Treat; 2011 Mar; 43(1):1-11. PubMed ID: 21509157
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of vascular endothelial growth factor in gastric cancer patients.
Eroğlu A
J Surg Oncol; 2011 Aug; 104(2):222. PubMed ID: 21381039
[No Abstract] [Full Text] [Related]
35. Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.
Li H; Adachi Y; Yamamoto H; Min Y; Ohashi H; Ii M; Arimura Y; Endo T; Lee CT; Carbone DP; Imai K; Shinomura Y
Cancer; 2011 Jul; 117(14):3135-47. PubMed ID: 21264842
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients.
Seo HY; Park JM; Park KH; Kim SJ; Oh SC; Kim BS; Kim YH; Kim JS
Jpn J Clin Oncol; 2010 Dec; 40(12):1147-53. PubMed ID: 20647232
[TBL] [Abstract][Full Text] [Related]
37. Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancer.
Kim YS; Hong J; Sym SJ; Park SH; Park J; Cho EK; Lee JH; Shin DB
Cancer Res Treat; 2010 Mar; 42(1):24-9. PubMed ID: 20369048
[TBL] [Abstract][Full Text] [Related]
38. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI.
Seo BG; Kwon HC; Oh SY; Lee S; Kim SG; Kim SH; Han H; Kim HJ
Oncol Rep; 2009 Jul; 22(1):127-36. PubMed ID: 19513514
[TBL] [Abstract][Full Text] [Related]
40. A nested case-control study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3.
Pham TM; Fujino Y; Kikuchi S; Tamakoshi A; Yatsuya H; Matsuda S; Yoshimura T;
Eur J Cancer; 2007 Jul; 43(10):1611-6. PubMed ID: 17532620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]